The Pentagon has pulled back recently issued testosterone screening guidance for male service members after posting, and then quickly removing, the policy from its official website, leaving questions about leadership and process within the Defense Department.
New guidelines requiring testosterone-deficiency screening for men in the military aged 30 and older appeared on the Defense Health Agency’s website on September 2, only to vanish the following day. The policy was part of Defense Secretary Pete Hegseth’s efforts to add hormone checks to annual exams for both active-duty and reserve personnel. According to initial reporting, a Pentagon spokesperson announced that “comprehensive clinical guidance” had been issued, outlining “uniform screening and treatment pathways” for service members.
But within 24 hours, the Pentagon had pulled the documents offline. A top adviser to Hegseth described the published policy as merely a “draft” that was “inadvertently” posted, while a U.S. official insisted the “Interim Guidance on Testosterone Deficiency Screenings for Active Duty and Reserve Component Personnel remains in effect.” The official added that “the final clinical guidance will be issued shortly.” The sudden reversal left military doctors and affected personnel in limbo, unsure about what rules would ultimately apply.
Pentagon says policy was a draft as internal disruption grows
The confusion comes just weeks after Hegseth issued a mid-July order seeking to add mandatory testosterone checks for men aged 30 and older, a move that sparked debate within military medical circles. The guidance, which would have imposed annual screening questionnaires for men and women in this age group and recommended further testing or treatment if indicated, was issued by the Defense Health Agency’s director and distributed to the Military Departments and medical providers. But as Newsmax reported, the Pentagon quickly rescinded the guidance “to allow for updates,” with both the memo and the accompanying statement from spokesperson Sean Parnell disappearing from official websites. Pages that once hosted the documents now show “Page Not Found.”
An unnamed official told Reuters, “The draft (document) published on September 2, 2026, has been temporarily rescinded to allow for updates.” This language aligns with the Pentagon’s attempt to frame the incident as an administrative hiccup rather than a policy backtrack. Still, the speed of the reversal and the lack of clear communication left many observers questioning whether Hegseth’s initiative faced internal resistance or was overruled behind closed doors.
This episode fits a broader pattern of controversy and disruption surrounding Hegseth’s leadership. In recent months, he has blocked several Army officer promotions, as seen in his latest intervention in Army promotions, and has presided over high-profile clashes with senior officials, including the recent resignation of Army Secretary Dan Driscoll. These actions have fueled debate about the stability and priorities of Pentagon leadership.
Hormone screening plan faces pushback and policy limbo
The brief appearance of the guidance documents revealed new details about Hegseth’s “High T” initiative. The program would have made testosterone testing mandatory for men over 30, with voluntary screening for younger male service members. According to the Washington Examiner, the withdrawn guidance also included screening recommendations for women experiencing menopause or related hormonal changes.
The Pentagon has maintained that it remains committed to addressing hormone deficiencies in the ranks. In a statement cited by multiple sources, a spokesperson said, “The Department remains committed to addressing hormone deficiencies, protecting the long-term health of its Service members, and enabling peak operational performance.” But the sudden withdrawal of the guidelines, without clear explanation, suggests that Hegseth’s plan is facing more obstacles than his office has admitted. The resignation of Army Secretary Dan Driscoll, after months of friction with Hegseth, underscores how deep the internal divisions run.
The Pentagon has not provided specifics on when a final version of the clinical guidance will be released or whether it will differ from the draft. No injuries or operational disruptions have been reported, but the reversal leaves the chain of command and medical staff waiting for clarity. This is not the first time Hegseth’s policy initiatives have been challenged or reversed, his halted promotion of Army officers linked to removed generals and his controversial press escort policies have also drawn scrutiny, with federal courts at times overruling or reinstating his decisions.
Hegseth’s pattern of reversals raises accountability questions
As Breitbart noted, Hegseth’s testosterone screening plan was billed as a way to boost operational performance by identifying and treating hormone deficiencies among military personnel. The reversal, however, highlights not only the lack of consensus within the department, but also a troubling pattern in which major policy changes are announced, only to be walked back or left in limbo.
Federal courts have recently weighed in on other Hegseth-led Pentagon decisions. In one case, a federal judge blocked Hegseth’s Pentagon press escort policy on First Amendment grounds, only for a higher court to later reinstate the requirement, as reported in a recent appeals court decision. The repeated pattern of abrupt announcements, legal challenges, and policy reversals points to a Pentagon leadership that often acts first and clarifies later, at the expense of stability for service members and their families.
In the end, the Pentagon’s failure to deliver clear, stable guidance, especially on issues as fundamental as military medical care, reflects a need for stronger leadership and better coordination. America’s men and women in uniform deserve no less.
